Research Progress of Metal Anticancer Drugs
Cancer treatments, including traditional chemotherapy, have failed to cure human malignancies. The main reasons for the failure of these treatments are the inevitable drug resistance and serious side effects. In clinical treatment, only 5 percent of the 50 percent of cancer patients who are able to...
Saved in:
Main Authors: | Yun Bai (Author), Gerile Aodeng (Author), Lu Ga (Author), Wenfeng Hai (Author), Jun Ai (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in the Application of the Fenton Reaction in the Cancer Microenvironment
by: Rile Ou, et al.
Published: (2023) -
Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections
by: Aviva Levina, et al.
Published: (2022) -
Research Progress of Metals and Alloys by Thermal Layering and Deposition
Published: (2023) -
Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents
by: Tatyana I. Shabatina, et al.
Published: (2023) -
Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma
by: Man Wang, et al.
Published: (2022)